Surgical Treatment for Hepatolithiasis with Hidden Intrahepatic Cholangiocarcinoma.
- Author:
Ju Ik MOON
1
;
Sung Ho JO
;
Hyoun Jong MOON
;
Jin Seok HEO
;
Seong Ho CHOI
;
Jae Won JOH
;
Yong Il KIM
;
Jong Kyun LEE
;
Kyu Teak LEE
Author Information
1. Department of Surgery, Samsung Medical Center, Sungkyunkwan University College of Medicine, Korea. gsshchoi@samsung.com
- Publication Type:Original Article
- Keywords:
Hepatolithiasis;
Intrahepatic cholangiocarcinoma;
Hepatic resection
- MeSH:
Bilirubin;
Biopsy;
Biomarkers, Tumor;
Cholangiocarcinoma*;
Cholangitis;
Diagnosis;
Dilatation;
Hand;
Humans;
Liver Abscess;
Lymphatic Diseases;
Necrosis;
Retrospective Studies
- From:Journal of the Korean Surgical Society
2004;67(5):379-383
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Hepatolithiasis causes many complications as well as an intrahepatic cholangiocarcinoma, which means that it should definitely be treated. However, it is difficult to make an accurate diagnosis for a concurrent cholangiocarcinoma prior to surgery. This study examined the surgical treatment for a hepatoithiasis with a hidden intrahepatic cholangiocarcinoma. METHODS: A retrospective analysis for patients who had undergone a hepatic resection for hepatolithiasis between September 1994 and July 2004 was made by comparing them in two groups. One group comprised of patients with hepatolithiasis only (group H) and the other group comprised of patients with hepatolithiasis and a hidden cholangiocarcinoma of which the preoperative diagnosis had failed (group HC). The prognostic factors, such as age, gender ratio (M: F), symptoms and the duration of their onset, tumor markers and total bilirubin, preoperative radiological findings, intraoperative findings, and operation type were analyzed. RESULTS: Group H consisted of 261 patients and the group HC consisted of 5. In group HC, 2 cases of tumor necrosis were misdiagnosed as a liver abscess, 1 case of hilar cholangiocarcinoma was misdiagnosed as severe cholangitis, and another case of intrahepatic cholangiocarcinoma was misdiagnosed as duct dilatation with periductal inflammatory proliferation. On the other hand, the presence of a history of a undergoing hepatobiliary surgery, the preoperative radiological findings of a liver abscess and lymphadenopathy, the type of surgery, and the site of the intrahepatic stones were statistically different in the two groups. CONCLUSION: A hidden cholangiocarcinoma should be suspected preoperatively in cases in whom there is a history of undergoing hepatobiliary surgery, the preoperative radiological findings of a liver abscess or lymphadenopathy. In addition, a meticulous exploration for a possible incidental tumor mass with an additional consultation of a frozen biopsy should be carried out intraoperatively to determine if the preoperative finding of a liver abscess is a tumor necrosis.
